1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price)
4. Sell on RSI close below 30 (or use any other method of your liking)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Weekly tailing tops with high volume
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
After a consolidation since August 2021,
AEGISCHEM
has given a breakout today. Buy with a stop just below ₹260.
Strengths: -
1. March 2021 Sales growth is at 20% and Profit growth is at 60%
2. 10 year average ROE at 15%
3. Debt to equity at 0.38 (less than 1 is good), Interest Coverage at 22.7 (greater than 3 is good), FCF to CFO at 50.1%
4. Company has been maintaining a healthy dividend payout of 38.0% (consistent dividend payer since 2011)
5. Credit rating agency has reaffirmed the ratings of the company on (please go through the credit rating report for better understanding)
6. ADX > 30 on daily chart
Weaknesses: -
1. Stock is trading at 4.65 times of its book value
2. The company has delivered a poor sales growth of 3.34% over past five years
3. Company has a low return on equity of 12.7% for last 3 years
4. Debtor days have increased from 30.1 to 58.2 days
5. Borrowings are increasing since March 2019
Disclaimer: I am not SEBI Registered. Do trade or invest at your own risk, I am not responsible for any losses and won't claim anything from your profits either. Take financial advices from your advisors before jumping in.
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss Amount/(Buy Price-Initial Stop Loss Price)
4. Sell on RSI close below 30 (or use any other method of your liking)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Weekly tailing tops with high volume
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
After a consolidation since August 2021,
AEGISCHEM
has given a breakout today. Buy with a stop just below ₹260. Strengths: -
1. March 2021 Sales growth is at 20% and Profit growth is at 60%
2. 10 year average ROE at 15%
3. Debt to equity at 0.38 (less than 1 is good), Interest Coverage at 22.7 (greater than 3 is good), FCF to CFO at 50.1%
4. Company has been maintaining a healthy dividend payout of 38.0% (consistent dividend payer since 2011)
5. Credit rating agency has reaffirmed the ratings of the company on (please go through the credit rating report for better understanding)
6. ADX > 30 on daily chart
Weaknesses: -
1. Stock is trading at 4.65 times of its book value
2. The company has delivered a poor sales growth of 3.34% over past five years
3. Company has a low return on equity of 12.7% for last 3 years
4. Debtor days have increased from 30.1 to 58.2 days
5. Borrowings are increasing since March 2019
Disclaimer: I am not SEBI Registered. Do trade or invest at your own risk, I am not responsible for any losses and won't claim anything from your profits either. Take financial advices from your advisors before jumping in.